|
HS Code |
611645 |
| Chemical Name | Dextran 40 |
| Molecular Weight | Approximately 40,000 Da |
| Appearance | White to off-white powder |
| Solubility | Freely soluble in water |
| Cas Number | 9004-54-0 |
| Ph Range | 5.0 - 7.5 (5% solution) |
| Storage Temperature | 2-8°C |
| Synonyms | Dextran T40, Dextran Type 40 |
| Source | Polysaccharide produced by Leuconostoc mesenteroides |
| Endotoxin Level | Typically <0.25 EU/mg |
| Solution Viscosity | Low viscosity relative to higher molecular weight dextrans |
| Use | Volume expander, research reagent |
| Stability | Stable under recommended storage conditions |
| Formula | (C6H10O5)n |
| Purity | ≥99% (biochemical grade) |
As an accredited Dextran 40 factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Dextran 40 is supplied in a sealed, amber glass bottle containing 100g of fine, white, hygroscopic powder, with tamper-evident cap. |
| Shipping | Dextran 40 should be shipped in tightly sealed containers, protected from moisture and light. It must be transported at ambient temperature unless specified otherwise, following local and international regulations for chemical substances. Ensure appropriate labeling and documentation, and avoid exposure to incompatible materials during transit. Handle with standard safety precautions. |
| Storage | Dextran 40 should be stored in a tightly closed container at controlled room temperature, ideally between 15°C and 30°C (59°F and 86°F), away from moisture, heat, and direct sunlight. The storage area should be well-ventilated, dry, and secure to prevent contamination. Keep away from incompatible substances and handle with recommended protective equipment to avoid exposure. |
Competitive Dextran 40 prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Dextran 40 has held its own in our production halls for decades. Many industries look at it only by its chemical name and see a polymer, one among many, but those behind the reactors and quality checks know the key lies in mastering the subtle variations that define Dextran 40’s unique profile. We use select grades of sucrose as our base carbohydrate, feeding controlled microbial fermentation. The resulting Dextran 40 sets itself apart with consistent molecular weight around 40,000 Da—hence the name—setting the foundation for its function across sectors.
This process isn’t just batch work. We track fermentation kinetics, optimize feeding rate, and closely control harvest time. The hydrolysis and subsequent fractionation steps are where real experience shows. Dextran 40 demands accuracy during hydrolysis: it’s easy to drift into lower or higher molecular weight fractions if timing varies or pH control slips. Each lot requires detailed GPC analysis and intrinsic viscosity checks before we release it, not only to uphold specifications, but also because certain medical, biotechnological, and food clients run applications that depend on precisely those molecular characteristics.
Dextran 40’s primary role, from where we stand, lies in medical and health-related industries. Physicians have counted on it in intravenous solutions as a plasma volume expander, especially useful in acute settings where rapid blood loss occurs. One of the biggest advantages, and something we aim to highlight, is its ability to manage oncotic pressure while being filtered efficiently by the kidneys. Experience has shown that higher-molecular-weight dextrans can linger in circulation, raising the risk of tissue deposition or interfering with blood cross-matching; with Dextran 40, this risk tapers off without sacrificing performance.
Outside hospitals, Dextran 40 sees demand in pharmaceutical formulation, acting as a stabilizer or bulking agent for certain injectables and lyophilized products. Beyond medicine, our long-term customers in laboratory diagnostics rely on Dextran 40 because its size and charge relationship ensures reliable separation in chromatography and cell separation tools. We get regular requests from research groups needing stable, reproducible lots that don’t drift in viscosity, because these factors impact column behavior or sedimentation rates.
One aspect often overlooked on paper but obvious after years of production is the way storage and package handling can impact Dextran 40’s consistency. Poor storage conditions—exposure to moisture, shifts in temperature—affect hygroscopic materials, and Dextran 40 picks up water readily. That seemingly trivial detail influences powder flow and dosing accuracy, so our warehouses maintain relative humidity below 40% and temperatures under 25°C. We use high-density polyethylene drums or multi-laminate bags, not just for regulatory compliance, but to genuinely protect quality through every kilometer of shipping.
Further, many assume all dextrans behave the same, regardless of weight or branching pattern. Our process engineers see the opposite daily. Dextran 40, compared to Dextran 70 or 10, strikes a distinct balance: it moves fast enough in blood, clears predictably, and interacts less with cell surfaces and plasma proteins than higher polymers. That lowers the occurrence of side effects like anaphylactoid reactions. In chromatographic scenarios, Dextran 40 delivers tighter, more symmetrical bands—something that’s tough to replicate with variants possessing broader molecular weights.
While official paperwork hints at standardized values, we understand real-world variation makes a difference. Dextran 40 is generally available as a white to off-white powder, highly soluble in water, yielding a solution with neutral pH (typically between 5.0 and 7.0 for a 10% solution). Levels of reducing sugar, ash content, microbial load—these are not just numbers to us, but daily performance benchmarks. We achieve endotoxin levels well below pharmacopeial cutoffs, and pay close attention to pyrogenicity, which remains critical for hospital customers.
In response to customer feedback, we offer various models: pharmaceutical grade for infusions, laboratory grade for binding or separation media, and food-grade material for specialty applications, such as texture modification in confectionery. Though each follows similar upstream chemistry, our analytics team certifies every lot by HPLC, GPC, limits tests for starch and protein, and bioburden counts. Our experience proves the value of strict process segregation, so customers don’t deal with cross-grade contamination or molecular drift that could throw off product performance.
Those new to Dextran 40 often underestimate the impact of handling practices. It dissolves cleanly in water, with moderate agitation, but chucking powder straight into a fast-moving impeller leads to clumping or foam, which then takes valuable process time to clear. Over the years, we’ve advised customers on how to scale up or scale out, calling for gradual addition and careful order-of-addition when mixing with salts or buffers.
In infusion product manufacture, filtration processes sometimes gum up if water temperature falls too low, as viscosity rises quickly with colder solutions. Operators familiar with starch or lower-weight dextrans sometimes get caught off guard here, so we support with practical blending recommendations and provide demo samples for pilot runs.
Dextran 40’s interaction with proteins shows up frequently in our technical support calls. In formulation labs, new staff may add Dextran 40 to protein therapeutics with minimal pretesting, only to find unexpected precipitation. We learned, after years of troubleshooting, to recommend small-batch mixing and to assay solution clarity. Batch consistency in our plant means our customers can trust results, but process scaling and excipient order always requires careful attention.
Over time, the market brings new polymers and hydrocolloids. We recognize alternatives such as hydroxyethyl starch or polyvinylpyrrolidone enter the conversation. Each brings nuances—hydroxyethyl starch, for example, introduces dose-dependent metabolism issues and carries distinct risk profiles. Polyvinylpyrrolidone offers different physicochemical properties and sometimes more regulatory hoops. We don’t claim Dextran 40 fits every case, but on the ground, customers note its lower toxicity, higher renal clearance, and less pronounced impact on coagulation pathways compared to some starch derivatives.
Many customers ask why not just use Dextran 70 or 10. In blood volume replacement, Dextran 70 has greater volume expansion, but lingers longer, raising the potential for circulatory overload and tissue accumulation, especially in compromised renal function. Dextran 10 clears rapidly and works well as an adjunct in some specialty pharmaceutical processes, but doesn’t maintain colloidal properties as long. Dextran 40 stakes out a middle ground: reliable volume support, with manageable clearance for most patients, and proven compatibility with blood transfusions. We witness the difference every run, as our QC labs routinely confirm predictable pharmacokinetics compared to other weights.
Regulatory demands have grown over the years, but to our plant, traceability never just meant keeping papers in tidy files. We laser-etch batch numbers on all storage drums, link in-house QC data to every shipment, and provide full certificates of analysis on demand. When recalls or regulatory checks happen, we backtrack from finished lot to fermentation, able to pinpoint process changes to the very hour. That isn’t just an audit exercise; customers in pharmaceuticals and clinical tools tell us that this depth of detail matters.
We also open our records for third-party audits on a regular basis, invite partners to walk our lines, and regularly field technical questions regarding molecular distribution, residual solvents, and potential allergens. We’ve adjusted our process over time—phasing out animal origin nutrients, increasing frequency of testing, switching to sustainably sourced inputs—based on these discussions. In our view, transparency isn’t about one-off disclosures, but about ongoing dialogue and readiness to address any concern as science evolves.
There’s a human side to manufacturing that specs and certifications never reveal. We’ve seen what happens if mixing order gets reversed, or if high-temperature drying pushes product outside water-content limits. One lesson we share with clients is that seemingly minor deviations early in the process ripple out: too much sodium hydroxide in hydrolysis, for instance, shifts the product’s final structure, and can lead to unwanted immunogenicity or overshooting viscosity targets.
Modern quality management puts real weight on prevention. Regular in-process monitoring and deviation tracking form the bedrock of how we approach Dextran 40. Our technicians calibrate their instruments before starting plant runs, perform on-spot presence checks for critical residues, and cross-verify each other’s measurements. We don’t shy away from destructive testing on finished lots, recognizing the risk to yield but holding firm on commitment to integrity over throughput.
Some customers approach us after disappointing experiences with generic substitutes—off-color product, persistent particulates, unexpected test failures. They want reliability in every drum, not just the documentation that travels with it. Our own troubleshooting teams step in to cross-examine root causes, provide impurity profiles, or demonstrate direct dissolution and filtration in their facilities. Many have seen firsthand that consistent Dextran 40 handling prevents the batch-to-batch surprises that can halt entire production lines.
Years of fielding questions from hospitals, formulators, and downstream processors shaped how we back up Dextran 40 in practice. We maintain a deep technical bench—chemical engineers, microbiologists, and long-tenured operators—ready to advise not just on specs but process tuning. Our lab sometimes replicates customer workflows, troubleshooting viscosity shifts or particle separation side-by-side, which builds trust and uncovers application-specific nuances.
For new application development, collaboration runs deep. Laboratories building new separation protocols consult with us before pilot runs, especially for microencapsulation or gradient formation processes sensitive to solution properties. We routinely dispatch samples at different molecular weights or packaging types, balancing customer needs for innovation with the consistency required by regulatory submissions. Industry consortia appreciate our contributions not just of product, but of process know-how: how sterilization techniques affect the polymer backbone, or how specific salts or pH adjusters fit with Dextran 40’s chemistry.
The feedback loop stretches both ways. We learn from users in unexpected ways—how a dialysis center reduced tubing blockages by modifying their Dextran 40 mixing procedure, or how a biotech firm found that very minor ionic impurities led to poor dye separations. Each story informs refinements on our process line, steering us away from purely theoretical metrics and into hands-on improvement.
The drive toward greener, more sustainable chemical production runs deep in our approach to Dextran 40. Sucrose sourcing has shifted, with preferences for suppliers meeting rigorous traceability standards and verified low-environmental-impact practices. Fermentation efficiency goes beyond output; we actively reduce waste, optimize water recovery, and recycle microbial biomass as fertilizer inputs for local agriculture.
Packaging presents another area of challenge and opportunity. While multi-layer polymers protect product integrity, leveraging recycled content or returnable containers remains an ongoing project. Our team works with logistics partners to reduce carbon footprints—smaller, more frequent shipments, strategic depot placement, and minimal transit time minimize risk to both product and environment.
Audits by NGOs and third parties motivate us to keep pushing for more sustainable, less energy-intensive processes. Reducing process water and switching to renewable energy where possible keep our facility in line with evolving brand and customer expectations. We see product stewardship not as a regulatory burden but as a mark of pride that carries through every lot we produce.
Production of Dextran 40 means a close relationship with safety—ours and the customer’s. Handling polysaccharide dust comes with explosion and inhalation risks no one finds in specification tables. We maintain dust abatement, electrostatic prevention, and PPE standards learned through years of close calls and after-action reviews. Our teams have moved from legacy process lines to fully contained transfer, leveraging vacuum systems and real-time particulate sensors.
Safety data sheets live in multiple languages at every station; no one steps into blending or packaging lines without hands-on refresher training. Emergency drills include likely and unlikely mishaps: from powder spills and cross-contamination to electrical or fire hazards. Our long-term staff know the difference careful housekeeping makes, and they pass those habits to each new intake, minimizing risk before the first hose gets opened each shift.
True value in Dextran 40 flows from steady hands, practiced routines, and tweak upon tweak over many years. We carry forward the insights gained from each customer and every deviation report, integrating production experience with the evolving demands of science and medicine. Our commitment won’t waver; we know that every bag, drum, or solution labeled Dextran 40 represents not just a chemical, but the accumulated knowledge and care of an entire operation. For our team, every lot stands as a testament to reliability, learning, and the shared goals of all who depend upon Dextran 40 in their work.